<i>TP</i>53 Mutational signature for aristolochic acid: an environmental carcinogen

Masaaki Moriya(Pharmac), Arthur P. Grollman(Stony Brook School), Bojan Jelaković(University Hospital Centre Zagreb), Sim Truong(Materials Systems (United States)), Zvonimir Medverec, Neda Slade(Augustana University), Branko Brdar(Ruđer Bošković Institute), Karla Tomić(College of Slavonski Brod), Lin Wu(Materials Systems (United States)), Andrea Fernandes(Pharmac)
International Journal of Cancer
March 16, 2011
10.1002/ijc.26077
Cited by 107

Related Papers

Fractionation and turnover of stable carbon isotopes in animal tissues: Implications for ?13C analysis of diet
|Oecologia|1983|1.8k
<i>TERT</i> promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
|Proceedings of the National Academy of Sciences|2013|1.4k
MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program
|Blood|2013|677
Aristolochic acid and the etiology of endemic (Balkan) nephropathy
|Proceedings of the National Academy of Sciences|2007|598
p63 and p73: Roles in Development and Tumor Formation
|Molecular Cancer Research|2004|492